Chatham Capital Group, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History

Chatham Capital Group, Inc.

$601 Million
Q3 2024

A detailed history of Chatham Capital Group, Inc. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Chatham Capital Group, Inc. holds 6,378 shares of XBI stock, worth $586,648. This represents 0.1% of its overall portfolio holdings.

Number of Shares

6,378

Previous 6,228 2.41%

Holding current value

$586,648

Previous $577,000 9.19%

% of portfolio

0.1%

Previous 0.1%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$90.87 - $102.43 $13,630 - $15,364	150 Added 2.41%	6,378 $630,000
Q2 2024 Jul 15, 2024	SELL	$82.22 - $94.12 $6,577 - $7,529	-80 Reduced 1.27%	6,228 $577,000
Q4 2023 Jan 19, 2024	SELL	$64.12 - $90.86 $5,770 - $8,177	-90 Reduced 1.41%	6,308 $563,000
Q1 2023 Apr 21, 2023	SELL	$73.13 - $91.97 $9,141 - $11,496	-125 Reduced 1.92%	6,398 $487,000
Q4 2022 Jan 31, 2023	SELL	$76.72 - $85.66 $3,836 - $4,283	-50 Reduced 0.76%	6,523 $541,000
Q3 2022 Oct 28, 2022	BUY	$75.06 - $94.9 $150 - $189	2 Added 0.03%	6,573 $521,000
Q2 2022 Aug 02, 2022	SELL	$62.81 - $96.09 $11,305 - $17,296	-180 Reduced 2.67%	6,571 $488,000
Q1 2022 Apr 21, 2022	SELL	$81.07 - $115.44 $231,860 - $330,158	-2,860 Reduced 29.76%	6,751 $607,000
Q4 2021 Feb 02, 2022	SELL	$108.77 - $134.15 $27,192 - $33,537	-250 Reduced 2.54%	9,611 $1.08 Million
Q3 2021 Oct 13, 2021	SELL	$118.69 - $138.49 $11,869 - $13,849	-100 Reduced 1.0%	9,861 $1.24 Million
Q2 2021 Jul 28, 2021	BUY	$122.48 - $139.69 $244 - $279	2 Added 0.02%	9,961 $1.35 Million
Q1 2021 Apr 29, 2021	BUY	$129.36 - $173.99 $4,268 - $5,741	33 Added 0.33%	9,959 $1.35 Million
Q4 2020 Jan 27, 2021	BUY	$110.36 - $151.14 $13,022 - $17,834	118 Added 1.2%	9,926 $1.4 Million
Q3 2020 Oct 22, 2020	BUY	$103.87 - $120.36 $6,024 - $6,980	58 Added 0.59%	9,808 $1.09 Million
Q2 2020 Jul 20, 2020	BUY	$73.26 - $114.17 $28,864 - $44,982	394 Added 4.21%	9,750 $1.09 Million
Q1 2020 May 01, 2020	SELL	$65.95 - $98.35 $2.95 Million - $4.4 Million	-44,759 Reduced 82.71%	9,356 $725,000
Q4 2019 Jan 31, 2020	SELL	$74.65 - $98.46 $423,265 - $558,268	-5,670 Reduced 9.48%	54,115 $5.15 Million
Q3 2019 Nov 08, 2019	SELL	$76.25 - $83.86 $154,406 - $169,816	-2,025 Reduced 3.28%	59,785 $4.56 Million
Q2 2019 Jul 24, 2019	BUY	N/A	705 Added 1.15%	61,810 $5.42 Million
Q1 2019 May 09, 2019	SELL	N/A	-2,340 Reduced 3.69%	61,105 $5.53 Million
Q4 2018 Feb 06, 2019	SELL	N/A	-10,040 Reduced 13.66%	63,445 $4.55 Million
Q3 2018 Oct 30, 2018	BUY	N/A	1,450 Added 2.01%	73,485 $7.05 Million
Q1 2018 May 09, 2018	BUY	N/A	1,265 Added 1.79%	72,035 $6.32 Million
Q4 2017 Feb 01, 2018	SELL	N/A	-1,600 Reduced 2.21%	70,770 $6.01 Million
Q3 2017 Nov 08, 2017	BUY	N/A	9,680 Added 15.44%	72,370 $6.27 Million
Q2 2017 Aug 09, 2017	BUY	N/A	62,690	62,690 $4.84 Million

Others Institutions Holding XBI

# of Institutions

927

Shares Held

101M

Call Options Held

28.4M

Put Options Held

33.4M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chatham Capital Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chatham Capital Group, Inc. with notifications on news.

Account

Chatham Capital Group, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History